Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 42

    1.

    A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.

    Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, Budoff M; CARE-2 Investigators.

    Am J Kidney Dis. 2008 Jun;51(6):952-65. Epub 2008 Apr 18.PMID: 18423809 [PubMed - indexed for MEDLINE]Related articles

    2.

    A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease.

    Fuchs S, Dib N, Cohen BM, Okubagzi P, Diethrich EB, Campbell A, Macko J, Kessler PD, Rasmussen HS, Epstein SE, Kornowski R.

    Catheter Cardiovasc Interv. 2006 Sep;68(3):372-8.PMID: 16892433 [PubMed - indexed for MEDLINE]Related articles

    3.

    Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment.

    Stewart DJ, Hilton JD, Arnold JM, Gregoire J, Rivard A, Archer SL, Charbonneau F, Cohen E, Curtis M, Buller CE, Mendelsohn FO, Dib N, Page P, Ducas J, Plante S, Sullivan J, Macko J, Rasmussen C, Kessler PD, Rasmussen HS.

    Gene Ther. 2006 Nov;13(21):1503-11. Epub 2006 Jun 22.PMID: 16791287 [PubMed - indexed for MEDLINE]Related articles

    4.

    A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities.

    Mundt AJ, Vijayakumar S, Nemunaitis J, Sandler A, Schwartz H, Hanna N, Peabody T, Senzer N, Chu K, Rasmussen CS, Kessler PD, Rasmussen HS, Warso M, Kufe DW, Gupta TD, Weichselbaum RR.

    Clin Cancer Res. 2004 Sep 1;10(17):5747-53.PMID: 15355902 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Increased revascularization efficacy after administration of an adenovirus encoding VEGF(121).

    Perrin LA, June JE, Rosebury W, Robertson A, Kovesdi I, Bruder JT, Kessler PD, Keiser JA, Gordon D.

    Gene Ther. 2004 Mar;11(6):512-21.PMID: 14999223 [PubMed - indexed for MEDLINE]Related articles

    6.

    Reflective journaling: developing an online journal for distance education.

    Kessler PD, Lund CH.

    Nurse Educ. 2004 Jan-Feb;29(1):20-4.PMID: 14726795 [PubMed - indexed for MEDLINE]Related articles

    7.

    Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.

    Rajagopalan S, Mohler ER 3rd, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler PD, Rasmussen HS, Annex BH.

    Circulation. 2003 Oct 21;108(16):1933-8. Epub 2003 Sep 22.PMID: 14504183 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model.

    Wang K, Kessler PD, Zhou Z, Penn MS, Forudi F, Zhou X, Tarakji K, Kibbe M, Kovesdi I, Brough DE, Topol EJ, Lincoff AM.

    Mol Ther. 2003 May;7(5 Pt 1):597-603.PMID: 12718902 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cell therapy in the heart: cell production, transplantation, and applications.

    Cahill KS, Toma C, Pittenger MF, Kessler PD, Byrne BJ.

    Methods Mol Biol. 2003;219:73-81. No abstract available. PMID: 12596999 [PubMed - indexed for MEDLINE]Related articles

    10.

    Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors.

    Fraites TJ Jr, Schleissing MR, Shanely RA, Walter GA, Cloutier DA, Zolotukhin I, Pauly DF, Raben N, Plotz PH, Powers SK, Kessler PD, Byrne BJ.

    Mol Ther. 2002 May;5(5 Pt 1):571-8.PMID: 11991748 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions.

    Crystal RG, Harvey BG, Wisnivesky JP, O'Donoghue KA, Chu KW, Maroni J, Muscat JC, Pippo AL, Wright CE, Kaner RJ, Leopold PL, Kessler PD, Rasmussen HS, Rosengart TK, Hollmann C.

    Hum Gene Ther. 2002 Jan 1;13(1):65-100.PMID: 11779413 [PubMed - indexed for MEDLINE]Related articles

    12.

    Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions.

    Harvey BG, Maroni J, O'Donoghue KA, Chu KW, Muscat JC, Pippo AL, Wright CE, Hollmann C, Wisnivesky JP, Kessler PD, Rasmussen HS, Rosengart TK, Crystal RG.

    Hum Gene Ther. 2002 Jan 1;13(1):15-63.PMID: 11779412 [PubMed - indexed for MEDLINE]Related articles

    13.

    Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart.

    Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD.

    Circulation. 2002 Jan 1;105(1):93-8.PMID: 11772882 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe disease.

    Pauly DF, Fraites TJ, Toma C, Bayes HS, Huie ML, Hirschhorn R, Plotz PH, Raben N, Kessler PD, Byrne BJ.

    Hum Gene Ther. 2001 Mar 20;12(5):527-38.PMID: 11268285 [PubMed - indexed for MEDLINE]Related articles

    15.

    Myoblast cell grafting into heart muscle: cellular biology and potential applications.

    Kessler PD, Byrne BJ.

    Annu Rev Physiol. 1999;61:219-42. Review.PMID: 10099688 [PubMed - indexed for MEDLINE]Related articles

    16.

    Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle.

    Pauly DF, Johns DC, Matelis LA, Lawrence JH, Byrne BJ, Kessler PD.

    Gene Ther. 1998 Apr;5(4):473-80.PMID: 9614571 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Cell-specific promoter in adenovirus vector for transgenic expression of SERCA1 ATPase in cardiac myocytes.

    Inesi G, Lewis D, Sumbilla C, Nandi A, Strock C, Huff KW, Rogers TB, Johns DC, Kessler PD, Ordahl CP.

    Am J Physiol. 1998 Mar;274(3 Pt 1):C645-53.PMID: 9530095 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.

    Kessler PD, Podsakoff GM, Chen X, McQuiston SA, Colosi PC, Matelis LA, Kurtzman GJ, Byrne BJ.

    Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14082-7.PMID: 8943064 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Movement of Ca(2+)-ATPase molecules within the sarcoplasmic/endoplasmic reticulum in skeletal muscle.

    Kaprielian Z, Robinson SW, Fambrough DM, Kessler PD.

    J Cell Sci. 1996 Oct;109 ( Pt 10):2529-37.PMID: 8923214 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: long-term survival and phenotypic modification of implanted myoblasts.

    Robinson SW, Cho PW, Levitsky HI, Olson JL, Hruban RH, Acker MA, Kessler PD.

    Cell Transplant. 1996 Jan-Feb;5(1):77-91.PMID: 8665080 [PubMed - indexed for MEDLINE]Related articles

    21.

    Sudden cardiac death in heart failure. The role of abnormal repolarization.

    Tomaselli GF, Beuckelmann DJ, Calkins HG, Berger RD, Kessler PD, Lawrence JH, Kass D, Feldman AM, Marban E.

    Circulation. 1994 Nov;90(5):2534-9. Review.PMID: 7955213 [PubMed - indexed for MEDLINE]Related articles

    22.
    23.

    Nucleotide sequences of avian cardiac and brain SR/ER Ca(2+)-ATPases and functional comparisons with fast twitch Ca(2+)-ATPase. Calcium affinities and inhibitor effects.

    Campbell AM, Kessler PD, Sagara Y, Inesi G, Fambrough DM.

    J Biol Chem. 1991 Aug 25;266(24):16050-5.PMID: 1831452 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    The erythrocyte sedimentation rate in congestive heart failure.

    Haber HL, Leavy JA, Kessler PD, Kukin ML, Gottlieb SS, Packer M.

    N Engl J Med. 1991 Feb 7;324(6):353-8.PMID: 1987458 [PubMed - indexed for MEDLINE]Related articles

    25.

    Diminished beta-adrenergic receptor responsiveness and cardiac dilation in hearts of myopathic Syrian hamsters (BIO 53.58) are associated with a functional abnormality of the G stimulatory protein.

    Feldman AM, Tena RG, Kessler PD, Weisman HF, Schulman SP, Blumenthal RS, Jackson DG, Van Dop C.

    Circulation. 1990 Apr;81(4):1341-52.PMID: 2156638 [PubMed - indexed for MEDLINE]Related articles

    26.

    Decreased bioactivity of the guanine nucleotide-binding protein that stimulates adenylate cyclase in hearts from cardiomyopathic Syrian hamsters.

    Kessler PD, Cates AE, Van Dop C, Feldman AM.

    J Clin Invest. 1989 Jul;84(1):244-52.PMID: 2544625 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Cumulative hemodynamic response to short-term treatment with flosequinan (BTS 49465), a new direct-acting vasodilator drug, in severe chronic congestive heart failure.

    Kessler PD, Packer M, Medina N, Yushak M.

    J Cardiovasc Pharmacol. 1988 Jul;12(1):6-11.PMID: 2459536 [PubMed - indexed for MEDLINE]Related articles

    28.

    Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunction.

    Packer M, Lee WH, Medina N, Yushak M, Bernstein JL, Kessler PD.

    J Am Coll Cardiol. 1987 Dec;10(6):1303-11.PMID: 3316343 [PubMed - indexed for MEDLINE]Related articles

    29.

    Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure.

    Packer M, Lee WH, Kessler PD, Medina N, Yushak M, Gottlieb SS.

    J Am Coll Cardiol. 1987 Oct;10(4):837-44.PMID: 2821091 [PubMed - indexed for MEDLINE]Related articles

    30.

    Prevention and reversal of nitrate tolerance in patients with congestive heart failure.

    Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, Yushak M.

    N Engl J Med. 1987 Sep 24;317(13):799-804.PMID: 3114637 [PubMed - indexed for MEDLINE]Related articles

    31.

    Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.

    Packer M, Kessler PD, Lee WH.

    Circulation. 1987 Jun;75(6 Pt 2):V56-64. Review.PMID: 3552317 [PubMed - indexed for MEDLINE]Related articles

    32.

    Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.

    Packer M, Lee WH, Medina N, Yushak M, Kessler PD, Gottlieb SS.

    Am J Med. 1987 Jun;82(6):1119-26.PMID: 3037896 [PubMed - indexed for MEDLINE]Related articles

    33.

    Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure.

    Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL, Kukin ML.

    Circulation. 1987 May;75(5 Pt 2):IV80-92. Review.PMID: 2882867 [PubMed - indexed for MEDLINE]Related articles

    34.

    Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure.

    Packer M, Lee WH, Medina N, Yushak M, Kessler PD.

    Ann Intern Med. 1987 Mar;106(3):346-54.PMID: 3028221 [PubMed - indexed for MEDLINE]Related articles

    35.

    Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failure.

    Kessler PD, Packer M.

    Am Heart J. 1987 Jan;113(1):137-43.PMID: 3799427 [PubMed - indexed for MEDLINE]Related articles

    36.

    Can we expect vasodilator therapy to prolong life in patients with congestive heart failure?

    Packer M, Lee WH, Kessler PD, Gottlieb SS.

    J Cardiovasc Pharmacol. 1987;9 Suppl 2:S73-5.PMID: 2441205 [PubMed - indexed for MEDLINE]Related articles

    37.

    Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system.

    Packer M, Lee WH, Kessler PD.

    Circulation. 1986 Oct;74(4):766-74.PMID: 3019586 [PubMed - indexed for MEDLINE]Related articles

    39.

    Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management.

    Packer M, Kessler PD, Gottlieb SS.

    Postgrad Med J. 1986;62 Suppl 1:179-82.PMID: 3022272 [PubMed - indexed for MEDLINE]Related articles

    40.

    The independency of choline transport and acetylcholine synthesis.

    Marchbanks RM, Kessler PD.

    J Neurochem. 1982 Nov;39(5):1424-33.PMID: 6750047 [PubMed - indexed for MEDLINE]Related articles

    41.

    Brain blood flow and metabolism after global ischemia and post-insult thiopental therapy in monkeys.

    Kofke WA, Nemoto EM, Hossmann KA, Taylor F, Kessler PD, Stezoski SW.

    Stroke. 1979 Sep-Oct;10(5):554-60.PMID: 116395 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Choline transport is not coupled to acetylcholine synthesis.

    Kessler PD, Marchbanks RM.

    Nature. 1979 Jun 7;279(5713):542-4. No abstract available. PMID: 450100 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...